Charles River Labs Intl Stock
Price
Target price
€172.10
€172.10
-0.230%
-0.4
-0.230%
€170.44
23.12.25 / Tradegate
WKN: 939391 / Symbol: CRL / Name: Charles River Lb / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Charles River Labs Intl Stock
The price for the Charles River Labs Intl stock decreased slightly today. Compared to yesterday there is a change of -€0.400 (-0.230%).
With 21 Buy predictions and not a single Sell prediction Charles River Labs Intl is an absolute favorite of our community.
However, we have a potential of -1.22% for Charles River Labs Intl as the target price of 170 € is below the current price of 172.1 €.
Pros and Cons of Charles River Labs Intl in the next few years
Pros
?
B****
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Comments
Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for CRL provided by MarketBeat
Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at Bank of America Corporation from a "neutral" rating to a "buy" rating. They now have a $225.00 price target on the stock.
Show more
Ratings data for CRL provided by MarketBeat
Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating.
Show more
Ratings data for CRL provided by MarketBeat
News
Charles River Laboratories Schedules Second-Quarter 2025 Earnings Release and Conference Call
Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2025 financial results on Wednesday, August 6th, before the market opens. A conference call has been scheduled
